Drug Safety

Adis, Springer Healthcare

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Drug Safety is a journal published by Adis, Springer Healthcare in New Zealand. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Adis, Springer Healthcare
ISSN
0114-5916 · 1179-1942
Country
New Zealand
Access
Not open access / not declared
Declared publication charge
4,390 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1990-01-01
  • PUBMED · 2010-01-01
Indexing
MEDLINE · PUBMED
APC
4,390 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
128 days received→accepted — computed from PubMed (n=95)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

4389

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

173

i10-index

2672

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
94%
ORCID iDs in current deposits
89%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
9002928
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacovigilance and Adverse Drug Reactions
  • Drug-Induced Adverse Reactions
  • Drug-Induced Adverse Reactions
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
Show all subjects (50)
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Drug-Induced Hepatotoxicity and Protection
  • Drug-Induced Hepatotoxicity and Protection
  • Pharmaceutical industry and healthcare
  • Pharmaceutical industry and healthcare
  • Pharmacological Effects and Toxicity Studies
  • Pharmacological Effects and Toxicity Studies
  • Patient Safety and Medication Errors
  • Patient Safety and Medication Errors
  • Pregnancy and Medication Impact
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Pregnancy and Medication Impact
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
  • Cardiac electrophysiology and arrhythmias
  • Cardiac electrophysiology and arrhythmias
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Statistical Methods in Clinical Trials
  • Statistical Methods in Clinical Trials
  • Inflammatory mediators and NSAID effects
  • Inflammatory mediators and NSAID effects
  • Pharmaceutical Quality and Counterfeiting
  • Poisoning and overdose treatments
  • Advanced Causal Inference Techniques
  • Poisoning and overdose treatments
  • Schizophrenia research and treatment
  • Schizophrenia research and treatment
  • Pharmaceutical Quality and Counterfeiting
  • Advanced Causal Inference Techniques
  • Academic integrity and plagiarism
  • Academic integrity and plagiarism
  • Epilepsy research and treatment
  • Epilepsy research and treatment
  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
  • Meta-analysis and systematic reviews
  • Meta-analysis and systematic reviews

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: